April 13, 2012 How Conflicted Experts Can Sway FDA Drug Approval Decisions: A Case Study on Yaz Francesca Grifo Former contributor
April 3, 2012 New Allegations of Political and Corporate Pressure on FDA Michael Halpern Former Contributor
March 30, 2012 GM Drives Away From Climate Denial, Dumps Heartland Institute David Friedman Former contributor
March 23, 2012 Five Reasons Congress Should Support Strong Conflict-of-Interest Standards at FDA Francesca Grifo Former contributor
March 19, 2012 Vioxx shows what happens when the drug safety system breaks down Francesca Grifo Former contributor
March 13, 2012 For Drugs and Medical Devices, It’s Still a Jungle Out There Michael Halpern Former Contributor
January 26, 2012 On Toxic Dioxin, Will the EPA Fold or Stand Tall? Francesca Grifo Former contributor
